Titlebook: Cancer Immunology; Bench to Bedside Imm Nima Rezaei Book 2021Latest edition Springer Nature Switzerland AG 2021 Cancer immunotherapy.Transl

尊严

Strategies to Target Tumor Immunosuppression,ile antigen-specific immune responses play a crucial role in tumor rejection, the tumor hampers these immune responses by creating an immunosuppressive microenvironment. Recently, major progress has been achieved in the field of cancer immunotherapy, and several groundbreaking clinical trials demons

上坡

CRACY

Gene Therapy and Genetic Vaccines,. Advances in designing tumor-selective viral and nonviral vectors allow for more efficient gene delivery. Clinically approved gene therapies can be classified into several approaches such as sensitizing tumors to chemotherapies, targeting angiogenesis, and restoring tumor suppressing functions. Adj

柔软

IRATE

Recent Advances in Haploidentical Hematopoietic Cell Transplantation for Pediatric Hematologic Malit it offers a potential readily available family donor to almost every patient. The application of h-HCT has particularly benefited minority populations who frequently do not find a suitable unrelated donor. Different options exist utilizing either T cell depletion strategies or T cell-replete graft

cruise

事先无准备

Type I Interferons: History and Perspectives as Immunotherapeutic Agents Against Cancer,cle to infect a host cell. Besides viral interference, since their discovery, IFNs have been further implicated in different processes linked to immunity and cancer. The family of IFNs has been divided into three categories according to biological properties and signaling pathways: type I IFNs (cons

愉快吗

T-Cell Immunotherapy: From Synthetic Biology to Clinical Practice, their ability to alter the tumor microenvironment. Polyclonal T-cell populations, T-cell clones, and T-cells engineered to express chimeric antigen receptors (CARs) have all been expanded in various ways outside the body and then reintroduced for therapeutic effect. From naturally occurring T-cell

溺爱

Servile